Clinton J Grubbs Selected Research

Cyclin A2

11/2013

Concordant effects of aromatase inhibitors on gene expression in ER+ Rat and human mammary cancers and modulation of the proteins coded by these genes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Clinton J Grubbs Research Topics

Disease

48	Neoplasms (Cancer) 01/2023 - 05/2002
34	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2002
17	Carcinogenesis 01/2023 - 05/2002
15	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 09/2004
8	Body Weight (Weight, Body) 09/2017 - 01/2002
4	Carcinoma (Carcinomatosis) 11/2014 - 11/2008
2	Adenoma (Adenomas) 10/2018 - 11/2009
2	Hyperplasia 06/2012 - 05/2005
2	Skin Neoplasms (Skin Cancer) 11/2009 - 02/2009
2	Adenocarcinoma 07/2006 - 05/2005
1	Inflammation (Inflammations) 01/2023
1	Prediabetic State (Prediabetes) 12/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2018
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 06/2018
1	Hypothyroidism 06/2018
1	Rhabdomyosarcoma 01/2018
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 09/2017
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 09/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 07/2016
1	Intestinal Neoplasms (Intestinal Cancer) 07/2016
1	Neuroblastoma 07/2015
1	Hyperlipidemias (Hyperlipidemia) 06/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2013

Drug/Important Bio-Agent (IBA)

25	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2023 - 01/2002
11	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2003
11	CarcinogensIBA 09/2019 - 05/2002
10	Bexarotene (LGD1069)FDA Link 01/2020 - 02/2005
10	hydroxide ionIBA 01/2020 - 03/2005
10	Retinoid X Receptors (Retinoid X Receptor)IBA 06/2018 - 08/2003
8	Estrogen ReceptorsIBA 01/2020 - 09/2007
8	RetinoidsIBA 01/2017 - 07/2002
7	Gefitinib (Iressa)FDA Link 01/2020 - 04/2008
7	Naproxen (Naprosyn)FDA LinkGeneric 01/2020 - 11/2009
7	Tamoxifen FDA LinkGeneric 01/2020 - 11/2003
7	Proteins (Proteins, Gene)FDA Link 11/2013 - 05/2003
6	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2023 - 07/2002
6	NitrosaminesIBA 09/2017 - 09/2004
4	UAB 30IBA 06/2014 - 08/2003
4	Alitretinoin FDA Link 06/2006 - 05/2002
3	Triglycerides (Triacylglycerol)IBA 11/2022 - 03/2013
3	Cyclin D1IBA 01/2020 - 05/2003
3	vorozoleIBA 01/2020 - 04/2008
3	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 03/2015
3	Lapatinib (GW572016)FDA Link 01/2019 - 08/2011
3	Aromatase InhibitorsIBA 09/2018 - 11/2013
3	LigandsIBA 06/2018 - 02/2009
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2014 - 07/2006
3	ErbB Receptors (EGF Receptor)IBA 05/2013 - 04/2008
3	OligonucleotidesIBA 07/2006 - 05/2004
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 07/2019
2	Sulindac (Copal)FDA LinkGeneric 01/2023 - 02/2014
2	RNA (Ribonucleic Acid)IBA 01/2021 - 09/2004
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 05/2013
2	Atorvastatin (Lipitor)FDA Link 01/2020 - 02/2009
2	Estrogens (Estrogen)FDA Link 09/2019 - 05/2009
2	Insulin (Novolin)FDA Link 09/2017 - 03/2015
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 07/2016 - 03/2013
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2016 - 07/2015
2	AcidsIBA 10/2015 - 08/2003
2	Eflornithine (Ornidyl)FDA Link 02/2014 - 05/2003
2	Tumor Viral Antigens (Large T Antigen)IBA 06/2012 - 05/2003
2	AzoxymethaneIBA 05/2012 - 11/2009
2	Phosphotransferases (Kinase)IBA 08/2011 - 07/2006
2	Messenger RNA (mRNA)IBA 09/2010 - 05/2009
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 02/2009 - 05/2002
2	Dihydrotachysterol (AT 10)IBA 04/2008 - 05/2002
2	tipifarnib (R115777)IBA 07/2006 - 04/2006
2	FenretinideIBA 02/2004 - 01/2002
1	Sulfides (Thioethers)IBA 01/2023
1	ProstaglandinsIBA 01/2023
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2023
1	SulfonesIBA 01/2023
1	sulindac sulfideIBA 01/2023
1	IsoenzymesIBA 01/2023
1	FructoseIBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	Tromethamine (Trometamol)FDA Link 09/2019
1	SaltsIBA 09/2019
1	Bile Acids and Salts (Bile Acids)IBA 07/2019
1	Urea (Carbamide)FDA LinkGeneric 12/2018
1	NucleotidesIBA 12/2018
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2018
1	Protein Kinase InhibitorsIBA 09/2018
1	MK 2206IBA 09/2018
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2017
1	benz(a)anthracene (benzanthracene)IBA 07/2016
1	TriterpenesIBA 07/2016
1	Therapeutic UsesIBA 10/2015
1	Omeprazole (Prilosec)FDA LinkGeneric 04/2015
1	Proton Pump InhibitorsIBA 04/2015
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 04/2015
1	BiguanidesIBA 03/2015
1	AMP-Activated Protein KinasesIBA 03/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2014
1	Cyclin A2IBA 11/2013

Therapy/Procedure

10	Therapeutics 01/2016 - 02/2005
9	Chemoprevention 11/2022 - 07/2002
2	Aftercare (After-Treatment) 09/2018 - 01/2016
1	Secondary Prevention 01/2013